Nicolai Tangen, CEO of the Norwegian Sovereign Wealth Fund, interviews Vasant Narasimhan, CEO of Novartis. The conversation covers Narasimhan's unique background as a physician and his approach to leading Novartis, focusing on significant scientific breakthroughs in early disease intervention and cell and gene therapies. They also discuss the impact of AI in pharmaceutical research and development, specifically Novartis's collaborations with companies like Isomorphic Labs. Finally, Narasimhan outlines three key changes he would make to the European pharmaceutical landscape, and shares his personal approach to health and wellness, emphasizing the importance of mindset, movement, nutrition, and recovery.
Sign in to continue reading, translating and more.
Open full episode in Podwise